Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Zyrexindo Mandiri Buana Tbk. (ZYRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 173.33B, 1.04M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. and Zyrexindo Mandiri Buana Tbk. are close in size by market cap, and Zyrexindo Mandiri Buana Tbk. is more actively traded (1.04M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | ZYRX | |
|---|---|---|
Market Cap | 172.82B | 173.33B |
Volume | 592.2K | 1.04M |
Lot | 5.92K | 10.41K |
Turnover | 147.05M | 134.49M |
Average Price | 248.31 | 129.19 |
Value | 147.05M | 134.49M |
Indicative Equilibrium Price | 254 | 129 |
Indicative Equilibrium Volume | 10 | 15 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Zyrexindo Mandiri Buana Tbk.
PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →
